These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3499736)

  • 1. Sustained ventricular tachycardia occurring during propafenone therapy.
    De Jaegere P; Huyghens L; Dewilde P
    Acta Cardiol; 1987; 42(3):207-12. PubMed ID: 3499736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P; Drago F; Di Donato RM; Cicini MP; Pasquini L; Marino B; Marcelletti C; Ragonese P
    Am Heart J; 1991 Oct; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant ventricular tachyarrhythmias in association with propafenone treatment.
    Buss J; Neuss H; Bilgin Y; Schlepper M
    Eur Heart J; 1985 May; 6(5):424-8. PubMed ID: 4043097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antiarrhythmic drugs in pediatric use: propafenone.
    Paul T; Janousek J
    Pediatr Cardiol; 1994; 15(4):190-7. PubMed ID: 7991437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA; Murdock CJ; Boone J; Kerr CR
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone.
    Stavens CS; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1985 Jul; 110(1 Pt 1):24-9. PubMed ID: 4013986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal left ventricular function does not protect against propafenone-induced incessant ventricular tachycardia.
    Millar RN; Lawrenson JB; Milne DA
    S Afr Med J; 1993 Apr; 83(4):256-9. PubMed ID: 8316922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC; Sorenson PB; Wood DL; Sugrue DD; Osborn MJ; Gersh BJ; Holmes DR
    Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant ventricular tachycardia during propafenone treatment in a child with junctional automatic tachycardia: effectiveness of intravenous molar sodium lactate.
    Scanu P; Grollier G; Guilleman D; Iselin M; Bustany P; Hurpe JM; Potier JC
    Pacing Clin Electrophysiol; 1991 May; 14(5 Pt 1):783-6. PubMed ID: 1712954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal ventricular tachycardia in association with propafenone, a new class IC antiarrhythmic agent.
    Nathan AW; Bexton RS; Hellestrand KJ; Camm AJ
    Postgrad Med J; 1984 Feb; 60(700):155-6. PubMed ID: 6709551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
    Lucet V; Do Ngoc D; Fidelle J; Sidi D; Batisse A; Loth P; Vrancea F; Villain E; Coumel P
    Arch Mal Coeur Vaiss; 1987 Aug; 80(9):1385-93. PubMed ID: 3122689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy and safety of intravenous propafenone in the acute treatment of spontaneous sustained ventricular tachycardia].
    Mestre JL; Moro C; Madrid AH; Novo L; Marín-Huerta E
    Rev Esp Cardiol; 1994 Jul; 47(7):461-7. PubMed ID: 8090973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.